(27 days)
No
The device description focuses on mechanical and functional equivalence to a predicate device, with added features like timing assist lights and modified labeling for different airway devices. There is no mention of AI or ML in the description, intended use, or performance studies.
Yes
The device is indicated for "temporary increase in blood circulation," which is a physiological effect on the body, making it a therapeutic device.
No
The device is indicated for "temporary increase in blood circulation," which is a therapeutic function, not for diagnosing a medical condition.
No
The device description explicitly states it is a "modified ResQPOD Circulatory Enhancer (CE) device" and describes mechanical and functional equivalence to a predicate device, indicating it is a physical medical device with hardware components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "temporarily increase in blood circulation." This is a physiological effect on the body, not a diagnostic test performed on samples taken from the body.
- Device Description: The description focuses on mechanical and functional equivalence to a predicate device and additions like timing assist lights and connectors for airway devices. These are related to the physical interaction with the patient's respiratory system, not the analysis of biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information based on laboratory testing.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The ResQPOD Circulatory Enhancer does not fit this description.
N/A
Intended Use / Indications for Use
The ResQPOD Circulatory Enhancer is indicated for home, hospital, clinic and emergency care use, for the temporary increase in blood circulation as directed by a physician or licensed practitioner.
Product codes
BWF, JOW
Device Description
The modified ResQPOD Circulatory Enhancer (CE) device is mechanically and functionally equivalent to the unmodified, predicate ResQPOD CE reviewed and cleared for market in 510(k) K022906. This 510(k) submission was provided to review the following feature additions:
- a) The addition of timing assist lights as a convenience to encourage proper inspiration rate through the ResQPOD CE;
- b) Modified labeling to support use of the ResQPOD CE on alternative adjunctive airway devices, such as a mouthpiece, facemask with an ISO standard 22 mm connector, and endotracheal tube;
- c) Provision for an ISO standard 15 mm to 22 mm adapter connector between the ResOPOD CE and the mouthpiece or facemask; and
- d) Modified labeling to support use of the ResOPOD CE in clinic and emergency care locations with patients who, in the judgment of a physician or licensed professional, may need circulatory enhancement as provided by the ResQPOD CE.
The modified ResQPOD CE device is applied to adjunctive airway devices such as a mouthpiece, facemask or endotracheal tube. The skin contact material components of the modified ResQPOD CE are the same as those reviewed and cleared to market with the ResQPOD CE, 510(k) K022906 and are commercially available devices for respiratory use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Home, hospital, clinic and emergency care use, for the temporary increase in blood circulation as directed by a physician or licensed practitioner.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The safety and effectiveness of use of the modified ResQPOD CE device was demonstrated by testing in compliance with the Design Control process. The intended use and technology of the modified ResOPOD CE device is substantially equivalent to the predicate, unmodified device. No new questions of safety or effectiveness are raised.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.5690 Incentive spirometer.
(a)
Identification. An incentive spirometer is a device that indicates a patient's breathing volume or flow and that provides an incentive to the patient to improve his or her ventilation.(b)
Classification. Class II (performance standards).
0
Advanced Circulatory Systems, Inc.
7615 Golden Triangle Drive (Suite A) Eden Prairie, MN 55344 (952) 947-9590 (telephone) (952) 942-8336 (facsimile)
510(k) Summary of Safety and Effectiveness
| Company Name: | Advanced Circulatory Systems, Inc.
7615 Golden Triangle Drive (Suite A)
Eden Prairie, MN 55344 |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Robert Cohen, Chief Executive Officer |
| Phone: | 952 947-9615 |
| Fax: | 952 942-8336 |
| Summary Date: | October 23, 2003 |
| Trade Name: | ResQPOD™ Circulatory Enhancer |
| Common Name: | Circulatory Enhancer |
| Classification Name: | The unmodified, predicate ResQPOD CE was found substantially
equivalent to:
21 CFR 868.5690 Incentive Spirometer
21 CFR 870.5800 Compressible Limb Sleeve |
Predicate Device:
| 510(k) | Manufacturer | Product Code | Class | Trade Name |
|---|---|---|---|---|
| K022906 | Advanced | |||
| Circulatory | ||||
| Systems, Inc. | BWF, JOW | II | ResQPOD™ Circulatory | |
| Enhancer |
1.0 Description of Device
The modified ResQPOD Circulatory Enhancer (CE) device is mechanically and functionally equivalent to the unmodified, predicate ResQPOD CE reviewed and cleared for market in 510(k) K022906. This 510(k) submission was provided to review the following feature additions:
- a) The addition of timing assist lights as a convenience to encourage proper inspiration rate through the ResQPOD CE;
- b) Modified labeling to support use of the ResQPOD CE on alternative adjunctive airway devices, such as a mouthpiece, facemask with an ISO standard 22 mm connector, and endotracheal tube;
2017年07月24日 10:47:00 PM 2017 07:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 11:00 PM 1
1
- c) Provision for an ISO standard 15 mm to 22 mm adapter connector between the ResOPOD CE and the mouthpiece or facemask; and
- d) Modified labeling to support use of the ResOPOD CE in clinic and emergency care locations with patients who, in the judgment of a physician or licensed professional, may need circulatory enhancement as provided by the ResQPOD CE.
2.0 Intended Use
The modified ResQPOD CE indication for use is:
The ResQPOD Circulatory Enhancer is indicated for home, hospital, clinic and emergency care use, for the temporary increase in blood circulation as directed by a physician or licensed practitioner.
3.0 Technological
The technology of the modified ResQPOD CE device for temporary increase in circulation is the same as the technology of the ResQPOD CE device, reference 510(k) K022906.
The modified ResQPOD CE device is applied to adjunctive airway devices such as a mouthpiece, facemask or endotracheal tube. The skin contact material components of the modified ResQPOD CE are the same as those reviewed and cleared to market with the ResQPOD CE, 510(k) K022906 and are commercially available devices for respiratory use.
4.0 Conclusions
The safety and effectiveness of use of the modified ResQPOD CE device was demonstrated by testing in compliance with the Design Control process. The intended use and technology of the modified ResOPOD CE device is substantially equivalent to the predicate, unmodified device. No new questions of safety or effectiveness are raised.
2
Public Health Service
Image /page/2/Picture/2 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features the department's emblem, which consists of a stylized caduceus-like symbol with three parallel lines representing the human form. The emblem is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.
NOV 2 0 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Advanced Circulatory Systems Incorporated c/o Mr. Gary Syring Quality and Regulatory Associates, LLC 800 Levanger Lane Stoughton, WI 53589
Re: K033401
Modified ResQPOD™ Circulatory Enhancer Regulation Number: 21 CFR 868.5690 and 21 CFR 870.5800 Regulation Name: Incentive Spirometer and Compressible Limb Sleeve Regulatory Class: Class II (two) Product Code: BWF and JOW Dated: October 23, 2003 Received: October 29, 2003
Dear Mr. Syring:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Gary Syring
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4648. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address
http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Megan May
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
1033401 510(k) Number (if known): _
Device Name: _ResQPOD Circulatory Enhancer, Modified
Indications For Use:
The ResQPOD Circulatory Enhancer is indicated for home, hospital, clinic and emergency care use, for the temporary increase in blood circulation as directed by a physician or licensed practitioner.
(PLEASE: DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Crefan mase
ovascular Devices
510(k) Number
(Optional Format 3-10-98)
39